Evidence map›Paper›PMID 36232883›Full record

ArticleInternational journal of molecular sciences2022

Crotalphine Modulates Microglia M1/M2 Phenotypes and Induces Spinal Analgesia Mediated by Opioid-Cannabinoid Systems.

Flavia S R Lopes, Aline C Giardini, Morena B Sant'Anna, Louise F Kimura, Michelle C Bufalo, Hugo Vigerelli, Vanessa O Zambelli, Gisele Picolo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Flavia S R LopesLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.
Aline C GiardiniLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.
Morena B Sant'AnnaLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-2682-3860
Louise F KimuraLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.
Michelle C BufaloLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.
Hugo VigerelliCenter of Excellence in New Target Discovery (CENTD), Instituto Butantan, São Paulo 05503-900, Brazil.ORCID 0000-0002-8197-2260
Vanessa O ZambelliLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.
Gisele PicoloLaboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0001-6784-8266
Instituto Butantan · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001São Paulo Research Foundation 2013/07467-1
6 · The paper itself

Abstract

Pain is a worldwide public health problem and its treatment is still a challenge since clinically available drugs do not completely reverse chronic painful states or induce undesirable effects. Crotalphine is a 14 amino acids synthetic peptide that induces a potent and long-lasting analgesic effect on acute and chronic pain models, peripherally mediated by the endogenous release of dynorphin A and the desensitization of the transient receptor potential ankyrin 1 (TRPA1) receptor. However, the effects of crotalphine on the central nervous system (CNS) and the signaling pathway have not been investigated. Thus, the central effect of crotalphine was evaluated on the partial sciatic nerve ligation (PSNL)-induced chronic neuropathic pain model. Crotalphine (100 µg/kg, p.o.)-induced analgesia on the 14th day after surgery lasting up to 24 h after administration. This effect was prevented by intrathecal administration of CB1 (AM251) or CB2 (AM630) cannabinoid receptor antagonists. Besides that, crotalphine-induced analgesia was reversed by CTOP, nor-BNI, and naltrindole, antagonists of

Indexed as

AnalgesiaCannabinoidsNeuralgiaAmino AcidsAnalgesicsAnalgesics, OpioidAnkyrinsbeta-EndorphinCannabinoid Receptor AntagonistsDynorphinsEnkephalin, MethionineHumansInterleukin-6LipopolysaccharidesMicrogliaMinocyclineAmino AcidsAnalgesicsAnalgesics, OpioidAnkyrinsbeta-EndorphinCannabinoid Receptor AntagonistsCannabinoidscrotalphineDynorphinsEnkephalin, MethionineInterleukin-6LipopolysaccharidesMinocyclinePeptidesReceptors, Opioidchronic painendogenous opioid releaseglial cellsM2 polarizationneuroimmune modulationneuropathic pain

Identifiers

PMID36232883
PMCPMC9569646
OpenAlexW4303699514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.